Fred Saad, MD, shares the design and outcomes of the SPARTAN study in patients with nmCRPC

Fred Saad, MD, shares the design and outcomes of the SPARTAN study in patients with nmCRPC

Dr. Saad, Professor and Chairman of Urology, University of Montreal Hospital Center, shares design and outcomes of the SPARTAN study comparing Erleada (apalutamide) + ADT to ADT alone in patients with non-metastatic castration-resistant prostate cancer

ภาพตัวอย่างวิดีโอ
Fred Saad, MD, shares the design and outcomes of the SPARTAN study in patients with nmCRPC
ภาพตัวอย่างวิดีโอ
Fred Saad MD, on SPARTAN study highlights for oncologists that do not specialize in prostate cancer
ภาพตัวอย่างวิดีโอ
Fred Saad, MD, shares impressions of the CARD study investigating cabazitaxel in nmCRPC patients
ภาพตัวอย่างวิดีโอ
Dr. Fred Saad comenta os resultados finais de sobrevida do estudo SPARTAN
ภาพตัวอย่างวิดีโอ
Fred Saad, MD, on genetic testing to be conducted in a patient with metastatic prostate cancer
ภาพตัวอย่างวิดีโอ
Fred Saad, MD, details safety concerns when presenting apalutamide + ADT to nmCRPC patients
ภาพตัวอย่างวิดีโอ
Dr. Saad on Apalutamide Combination for Castration-Resistant Prostate Cancer